Tesaro, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

Latest Posts

About This Stock More About This Stock
Week In Review: Another Billion Dollar Week For China Life Science Deals
Article By: ChinaBio® Today
Saturday, September 30, 2017 5:55 PM EST
Shanghai Pharma Holding (SHA: 601607) may acquire part of Alvogen -- possibly Alvogen's US operations -- according to Bloomberg. Alvogen is a US-based generic drug maker thought to be worth as much as $4 billion.
In this article: NVO, SNY, SVA, AMGN, GILD, ZLAB, TSRO
Read
Citi Sees Advantage For Tesaro Despite Broad Lynparza Label
Article By: The Fly
Friday, August 18, 2017 6:00 AM EST
Citi analyst Robyn Karnauskas says the "broad label" given yesterday to AstraZeneca's Lynparza increases competition for Tesaro.
In this article: AZN, TSRO Also: CLVS
Read
Biotech Fades After ASCO Abstract Rally
Article By: Rod Raynovich
Friday, May 26, 2017 6:29 PM EST
Biotechs faded today now that the rush of oncology drug news cooled down. Today was dominated by the “red screen” with profit taking mainly in smaller caps and momentum driven oncology stocks.
In this article: MRK, ALNY, ALXN, BMRN, INCY, CELG, CLVS, VRTX, ZIOP, JUNO, PBYI, EPZM, GLYC, KITE, TSRO
Read
Tesaro Drops After Zejula Pricing, Competing PARPi Trial Miss
Article By: The Fly
Thursday, April 20, 2017 1:03 PM EST
The shares of drug maker Tesaro are falling with two possible headwinds cited by analysts as the potential culprit, namely the pricing of its niraparib treatment and the disappointing trial results of another drug in the same therapeutic space.
In this article: TSRO Also: ABBV, CLVS, MRK
Read
9 Blockbuster Drugs Making Their Debut In 2017; Total Revenue Expected To Be $16B By 2021
Article By: Lorimer Wilson
Tuesday, April 11, 2017 11:56 PM EST
It is always interesting to see what analysts believe the big new drugs of the year are going to be worth 5 years down the road and Clarivate Analytics has listed the 9 blockbusters their analysts expect to see approved by the FDA this year.
In this article: AZN, LLY, MRK, NVO, NVS, PFE, SNY, RHHBY, INCY, REGN, KITE, TSRO
Read

PARTNER HEADLINES

Latest Tweets for $TSRO

No tweets yet!

$TSRO

Alert: Alzheimer’s Drug Fails In Clinical Trial - Stocks Sink
Craig Newman 11/24/2016 5:28:00 AM

What are the chances of $BIIB and $TSRO being bought out? They have long been targets, or at least rumored to be, for consolidation.

1 to 1 of 1 comments